This study offers useful findings demonstrating the cartilage-protective effects of osteoactivin in inflammatory experimental models. The study provides compelling evidence that osteoactivin may serve ...

Investing a modest amount of money in growth stocks can generate massive returns. There is risk with putting money into ...

Merck & Co – known as MSD outside of the US and Canada – has unveiled a new cost-cutting plan aimed at saving $3bn every year by the end of 2027.

Merck & Co., Inc. (NYSE: MRK) is one of the most undervalued blue chip stocks to buy according to hedge funds. On July 21, ...

Employees of the technology transfer center ANAXAM and researchers from the Paul Scherrer Institute PSI used the unique ...

Celonis bullish on India's growing global capability centre landscape, offering process intelligence through digital twins to ...